Effect of Angiotensin II on arteriovenous shunting assessed by hepatic arterial perfusion scintigraphy

American Journal of Clinical Oncology: Cancer Clinical Trials

Volumn 20, Issue 3, 1997, Pages 237-241

  Inoue, Yusuke ^a   Machida, Kikuo ^b   Honda, Norinari ^b   Takagi, Shunji ^b   Ohtake, Tohru ^a   Nishikawa, Junichi ^a   Sasaki, Yasuhito ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b SAITAMA MEDICAL UNIVERSITY   (Japan)

Author keywords

Angiotensin II; Arteriovenous shunt; Hepatic tumor; Intraarterial chemotherapy; Technetium 99m macroaggregated albumin

Indexed keywords

ANGIOTENSIN; MACROSALB TC 99M;

ADULT; AGED; ARTERIOVENOUS SHUNT; ARTICLE; BILE DUCT CARCINOMA; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG ACCUMULATION; DRUG DELIVERY SYSTEM; FEMALE; GALLBLADDER CARCINOMA; HEPATIC ARTERY; HUMAN; INTRAARTERIAL DRUG ADMINISTRATION; LIVER CELL CARCINOMA; LIVER METASTASIS; MALE; SCINTIGRAPHY;

ADULT; AGED; ANGIOTENSIN II; ANTINEOPLASTIC AGENTS; ARTERIOVENOUS FISTULA; DRUG DELIVERY SYSTEMS; FEMALE; HUMANS; INFUSIONS, INTRA-ARTERIAL; LIVER CIRCULATION; LIVER NEOPLASMS; MALE; MIDDLE AGED; TECHNETIUM TC 99M AGGREGATED ALBUMIN; TISSUE DISTRIBUTION; VASOCONSTRICTOR AGENTS;

EID: 0030905526     PISSN: 02773732     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000421-199706000-00005     Document Type: Article

References (14)

1. Breedis C, Young G. The blood supply of neoplasms in the liver. Am J Pathol 1954;30:969-86.
2. Barone RM, Byefield JE, Goldfarb P, et al. Intra-arterial chemotherapy using an implantable infusion pump and liver irradiation for the treatment of hepatic metastases. Cancer 1982;50:850-62.
3. Sasaki Y, Imaoka S, Hasegawa Y, et al. Changes in distribution of hepatic blood flow induced by intra-arterial infusion of angiotensin II in human hepatic cancer. Cancer 1985;55:311-6.
4. Goldberg JA, Thomson JAK, Bradnam MS, et al. Angiotensin II as a potential method of targeting cytotoxic-loaded microspheres in patients with colorectal liver metastases. Br J Cancer 1991;64:114-9.
5. Krylova NV. Characteristics of microcirculation in experimental tumors. Bibl Anat 1969;10:301-3.
6. 131I-macroaggregated liver scanning and selective hepatic angiography. J Nucl Med 1970;11:196-202.
7. Bledin AG, Kim EE, Haynie TP. Technetium Tc-99m-macroaggregated albumin angiography and perfusion. JAMA 1983; 250:941-3.
8. Zeissman HA, Thrall JH, Yang PJ, et al. Hepatic arterial perfusion scintigraphy with Tc-99m-MAA. Radiology 1984;152: 167-72.
9. Borzutzky CA, Turbiner EH. The predictive value of hepatic arterial perfusion scintigraphy. J Nucl Med 1985;26:1153-6.
10. Goldberg JA, Bradnam MS, Kerr DJ, et al. Arteriovenous shunting of microspheres in patients with colorectal liver metastases: Errors in assessment due to free pertechnetate, and the effect of AT II. Nucl Med Commun 1987;8:1033-46.
11. Andrews JC, Walker-Andrews SC, Juni JE, et al. Modulation of liver tumor blood flow with hepatic arterial epinephrine: A SPECT study. Radiology 1989;173:645-7.
12. Kaplan WD, Come SE, Takvorian RW, et al. Pulmonary uptake of technetium 99m macroaggregated albumin: A predictor of gastrointestinal toxicity during hepatic artery perfusion. J Clin Oncol 1984;2:1266-9.
13. Wollner IS, Knutsen C, Smith P, et al. Effects of hepatic arterial yttrium 90 glass microspheres in dogs. Cancer 1988;61:1336-44.
14. Fujimoto S, Miyazaki M, Endoh F, et al. Effects of intra-arterially infused biodegradable microspheres containing mitomycin C. Cancer 1985;55:522-6.